Current Radiopharmaceuticals

Papers
(The TQCC of Current Radiopharmaceuticals is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Lung Cancer and Radiological Imaging28
FDG PET/CT in the Staging of Lung Cancer26
Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas19
Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial17
In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells16
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)15
Artificial Neural Networks in Cardiovascular Diseases and its Potential for Clinical Application in Molecular Imaging15
PET/CT and the Response to Immunotherapy in Lung Cancer15
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art14
Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-4714
IAEA Activities on 67Cu, 186Re, 47Sc Theranostic Radionuclides and Radiopharmaceuticals12
Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects12
Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.12
Alternative and New Radiopharmaceutical Agents for Lung Cancer11
Calcium Carbonate Microparticles as Carriers of 224 Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer9
Evidence-Based Data About Prevalence and Risk of Malignancy of Thyroid Incidentalomas Detected by Different PET Radiopharmaceuticals9
A Review of Accelerator-Produced Ga-68 with Solid Targets8
A Rapid and Specific HPLC Method to Determine Chemical and Radiochemical Purity of [68>Ga]Ga-DOTA-Pentixafor (PET) Tracer: Development and Validation6
Oxidant and Antioxidant Effects of Gentisic Acid in a 177Lu-Labelled Methionine-Containing Minigastrin Analogue6
Imperatorin Attenuates the Proliferation of MCF-7 Cells in Combination with Radiotherapy or Hyperthermia6
Feasibility of a Scale-down Production of [68Ga]Ga-NODAGA-Exendin-4 in a Hospital Based Radiopharmacy6
Assessment of Radiation Exposure Dose for Nuclear Medicine Workers from 18F-FDG, 99mTc MDP, and 99mTc5
Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease5
Radiotherapy Planning and Molecular Imaging in Lung Cancer5
Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts5
Automated Radiosynthesis and Molecular Docking Studies of Coumarin- Triazole Hybrid with fluorine-18: A feasibility study5
Usefulness of 5 Minutes 123I-mIBG Scan in Parkinson’s Disease and Heart Failure5
The Radiosensitizing Effect of Olanzapine as an Antipsychotic Medication on Glioblastoma Cell5
Thymoquinone Glucuronide Conjugated Magnetic Nanoparticle for Bimodal Imaging and Treatment of Cancer as a Novel Theranostic Platform4
Comparison of Two Types of Amino Acid Solutions on 177Lu-Dotatate Pharmacokinetics and Pharmacodynamics in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors4
Synthesis of 225Ac-PSMA-617 for Preclinical Use4
Discovery and Design of Radiopharmaceuticals by In silico Methods4
Analysis of Cell Fraction of 99mTc-HMPAO Radiolabeled Leukocytes4
Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation- Induced Small Intestine Injury4
Experimental Breast Cancer Models: Preclinical Imaging Perspective4
Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions3
Emerging Molecular Targets for Imaging of Atherosclerotic Plaque using Positron Emission Tomography3
The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strateg3
Direct incorporation of [18F] into Aliphatic Systems: A promising Mn-catalysed Labelling Technique for PET Imaging3
Molecular Imaging of Myocardial Inflammation: More Evidence Toward a Causative Role in Cardiovascular Disease3
Current State of 44Ti/44Sc Radionuclide Generator Systems and Separation Chemistry3
Gonioprobe, an Innovative Gamma-probe to Guide Parathyroid Radioguided Surgery: First Clinical Experiences with Navigator and Lock-ontarget Functions3
Evaluation of the Effect of Chelating Arms and Carrier Agents on t he Radiotoxicity of TAT Agents2
Animal Models for the Evaluation of Theranostic Radiopharmaceuticals2
Head and Neck Cancer Treatments through Chemotherapy to Magnetic Systems: Perspectives and Challenges2
New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications2
Analytical GC-FID Method for the Determination of Organic Solvents in Radiopharmaceuticals2
Nuclear Imaging of Post-infarction Inflammation in Ischemic Cardiac Diseases - New Radiotracers for Potential Clinical Applications2
Extremity Exposure with 99mTc - Labelled Radiopharmaceuticals in Diagnostic Nuclear Medicine2
Radiopharmaceutical Encapsulated Liposomes as a Novel Radiotracer Im - aging and Drug Delivery Protocol2
Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases2
90Y-DOTA-Nimotuzumab: Synthesis of a Promising β− Radiopharmaceutical2
Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration2
Ferulago angulata as a Good Radioprotector Against Genotoxicity2
Preclinical Assessment of [68Ga]Ga-Cell Death Indicator (CDI): A Novel hsp90 Ligand for Positron Emission Tomography of Cell Death2
Cardiac Injury Following Chemo/Radiation Therapy: An Updated Review on Mechanisms and Therapeutic Approaches2
Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies2
Radioiodination of Pimonidazole as a Novel Theranostic Hypoxia Probe2
0.034641027450562